IL33 and ocular melanoma: FACS analysis of proliferation marker Ki67 expression within IL‐33‐treated PDLSCs and DPSCs in GM, as well as in OM, showed high percentage of Ki67‐positive cells (over 92% per cent) in all examined groups (Figure 4B).